Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results

AIM: To assess the real-world effectiveness and cost of simeprevir (SMV), and/or sofosbuvir (SOF)-based therapy for chronic hepatitis C virus (HCV) infection. METHODS: The real-world performance of patients treated with SMV/SOF ± ribavirin (RBV), SOF/RBV, and SOF/RBV with pegylated-interferon (PEG)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Virol
Autors principals: Bichoupan, Kian, Tandon, Neeta, Crismale, James F, Hartman, Joshua, Del Bello, David, Patel, Neal, Chekuri, Sweta, Harty, Alyson, Ng, Michel, Sigel, Keith M, Bansal, Meena B, Grewal, Priya, Chang, Charissa Y, Leong, Jennifer, Im, Gene Y, Liu, Lawrence U, Odin, Joseph A, Bach, Nancy, Friedman, Scott L, Schiano, Thomas D, Perumalswami, Ponni V, Dieterich, Douglas T, Branch, Andrea D
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2017
Matèries:
Observational Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680347/
https://ncbi.nlm.nih.gov/pubmed/29147645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5501/wjv.v6.i4.59
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars